Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study…

By Claus G. Roehrborn, Peter Boyle, D. Bergner, Todd Gray, M. Gittelman, T. Shown, Arnold Melman, R. Bracken, R. W. D. White, A. Taylor and 2 more. 1999

Subfields: Medical & Health AI

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. R. Toth
2. B. Bloch
3. Anant Madabhushi
4. S. Pungavkar
5. R. Lenkinski
6. Elisabeth Genega
7. Mark A. Rosen
8. N. Rofsky

Citations in the corpus

• Accurate prostate volume estimation using multifeature active shape models on T2-weighted MRI. (2011, background): “P rostate volume has been shown to be a strong predictor of treatment outcome for patients with prostate cancer (1,2), especially when combined with a baseline prostate-specific antigen (PSA) level (3).”